Novo to buy Catalent: the backlash begins
Under the terms of the deal, Novo Holdings will sell three of Catalent’s fill-finish sites to Novo Nordisk, in which Novo Holdings has a controlling interest.
Under the terms of the deal, Novo Holdings will sell three of Catalent’s fill-finish sites to Novo Nordisk, in which Novo Holdings has a controlling interest.
